Clearmind Medicine, Inc. (CMND)
1.68
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 13:00
Clearmind Medicine Total Assets (Quarterly) : 14.52M for April 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 14.52M |
| January 31, 2026 | 11.14M |
| October 31, 2025 | 6.083M |
| July 31, 2025 | 3.970M |
| April 30, 2025 | 5.180M |
| January 31, 2025 | 6.585M |
| October 31, 2024 | 7.255M |
| July 31, 2024 | 8.173M |
| April 30, 2024 | 8.846M |
| January 31, 2024 | 10.10M |
| October 31, 2023 | 5.953M |
| July 31, 2023 | 4.488M |
| April 30, 2023 | 5.996M |
| January 31, 2023 | 4.657M |
| October 31, 2022 | 0.8269M |
| July 31, 2022 | 0.8948M |
| April 30, 2022 | 1.625M |
| Date | Value |
|---|---|
| January 31, 2022 | 2.563M |
| October 31, 2021 | 4.162M |
| July 31, 2021 | 5.657M |
| April 30, 2021 | 1.597M |
| January 31, 2021 | 0.3388M |
| October 31, 2020 | 0.3845M |
| July 31, 2020 | 0.4398M |
| April 30, 2020 | 0.4832M |
| January 31, 2020 | 0.1346M |
| October 31, 2019 | 0.1357M |
| July 31, 2019 | 0.1442M |
| April 30, 2019 | 0.1556M |
| January 31, 2019 | 0.1668M |
| October 31, 2018 | 0.1879M |
| July 31, 2018 | 0.1918M |
| April 30, 2018 | 0.2307M |
| January 31, 2018 | 0.246M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 9.134M |
| NervGen Pharma Corp. | 63.57M |
| Milestone Pharmaceuticals, Inc. | 181.62M |
| Lexaria Bioscience Corp. | 4.781M |
| Target Group, Inc. (Canada) | 5.678M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.033M |
| Shareholders Equity (Quarterly) | 11.49M |
| Debt to Equity Ratio | 0.0075 |
| Current Ratio | 4.793 |
| Net Debt Paydown Yield | -0.11% |